http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20010011004-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_319a34433f057def093a1eefa8f0f912 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-0295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-84 |
| filingDate | 1999-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de6f6ed888f5b6d7779475035851cc4b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c07f00d326fcb3aab98b753798e52c0c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b3c0f244bac300000e71928f2439ebb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cd9945e5dbca3491954ad53d2127b4b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bde4a4fe778758eae5ee304263e702dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27a5aa9262fae7e80f011209d0b42404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ca5f04a8ff2a5021f7048f2ffb29398 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63dfd138099fb12fa48b5bb5efb58770 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f0fb922da955f005030bbea6c1a3af6 |
| publicationDate | 2001-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20010011004-A |
| titleOfInvention | Lyotropic liquid crystalline compound and a method for the preparation thereof |
| abstract | The present invention relates to a novel concentration transition liquid crystal crystalline compound represented by the following general formula (I) and a method for producing the same, having the characteristics of the concentration transition liquid crystal forming compound.n n n (Ⅰ)n n n (In the above formula,n n n m is an integer between 0 and 60,n n n A1 and A2 are the same as or different from each other, and are hydrogen or an alkyl group having 1 to 31 carbon atoms, straight or branched chain, saturated or unsaturated, with or without a hydroxyl group,n n n B has the following structure,n n n or n n n R1 and R2 are the same as or different from each other, and are an alkyl group containing 1 to 31 carbon atoms, straight or branched chain, saturated or unsaturated, or not containing a hydroxyl group.n n n The concentration transition type liquid crystal forming compound (I) of the present invention is a substance having no irritation on the skin, and when applied to the skin to emulsify to form stable liquid crystal, it can supply continuous moisture to dry skin, and Recovery and prevention can be prevented, the recrystallization of natural ceramide can be suppressed to increase the amount of the compound, and the solubility in the solvent can be used without limitation in the content when formulated in the cosmetics. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006118245-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5271538-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9095560-B2 |
| priorityDate | 1999-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 132.